Wolverine Trading, LLC Intra Cellular Therapies, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$67.99 - $80.84 $557,518 - $662,888	8,200 New	8,200 $599,000
Q1 2024 May 15, 2024	SELL	$64.37 - $75.65 $856,121 - $1.01 Million	-13,300 Reduced 66.5%	6,700 $463,000
Q4 2023 Feb 14, 2024	BUY	$46.37 - $73.65 $927,400 - $1.47 Million	20,000 New	20,000 $1.43 Million
Q1 2023 May 15, 2023	SELL	$43.8 - $56.99 $4,380 - $5,699	-100 Reduced 1.59%	6,200 $348,000
Q4 2022 Feb 14, 2023	SELL	$44.07 - $54.45 $339,339 - $419,265	-7,700 Reduced 55.0%	6,300 $333,000
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $597,800 - $839,860	14,000 New	14,000 $634,000
Q2 2022 Aug 15, 2022	SELL	$43.0 - $65.64 $262,300 - $400,404	-6,100 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$38.74 - $62.09 $991,744 - $1.59 Million	-25,600 Reduced 80.76%	6,100 $368,000
Q4 2021 Feb 14, 2022	BUY	$35.2 - $53.42 $369,600 - $560,910	10,500 Added 49.53%	31,700 $1.65 Million
Q3 2021 Nov 12, 2021	BUY	$28.72 - $42.49 $430,800 - $637,350	15,000 Added 241.94%	21,200 $759,000
Q2 2021 Aug 06, 2021	BUY	$29.3 - $44.5 $181,660 - $275,900	6,200 New	6,200 $246,000
Q1 2021 May 14, 2021	SELL	$30.8 - $39.51 $498,960 - $640,062	-16,200 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$23.34 - $32.22 $256,740 - $354,420	-11,000 Reduced 40.44%	16,200 $522,000
Q3 2020 Nov 13, 2020	SELL	$17.61 - $31.86 $49,308 - $89,208	-2,800 Reduced 9.33%	27,200 $695,000
Q2 2020 Aug 13, 2020	SELL	$14.35 - $26.64 $73,185 - $135,864	-5,100 Reduced 14.53%	30,000 $755,000
Q1 2020 May 11, 2020	SELL	$12.31 - $33.12 $674,588 - $1.81 Million	-54,800 Reduced 60.96%	35,100 $555,000
Q4 2019 Feb 12, 2020	BUY	$7.26 - $38.49 $478,434 - $2.54 Million	65,900 Added 274.58%	89,900 $3.03 Million
Q3 2019 Nov 14, 2019	SELL	$7.47 - $14.03 $162,846 - $305,854	-21,800 Reduced 47.6%	24,000 $180,000
Q2 2019 Aug 20, 2019	SELL	$10.65 - $14.29 $335,475 - $450,135	-31,500 Reduced 40.75%	45,800 $594,000
Q1 2019 May 15, 2019	BUY	$10.9 - $14.09 $556,990 - $719,999	51,100 Added 195.04%	77,300 $942,000
Q4 2018 Feb 14, 2019	SELL	$10.36 - $20.96 $73,556 - $148,816	-7,100 Reduced 21.32%	26,200 $295,000
Q3 2018 Nov 14, 2018	SELL	$17.77 - $22.9 $431,811 - $556,470	-24,300 Reduced 42.19%	33,300 $723,000
Q1 2018 May 15, 2018	BUY	$15.16 - $25.49 $348,680 - $586,270	23,000 Added 66.47%	57,600 $1.21 Million
Q4 2017 Feb 14, 2018	BUY	$14.27 - $16.79 $118,441 - $139,357	8,300 Added 31.56%	34,600 $501,000
Q3 2017 Nov 15, 2017	BUY	$10.77 - $22.1 $283,251 - $581,230	26,300	26,300 $415,000

Others Institutions Holding ITCI

# of Institutions

378

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$794 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.32M
Shares

$521 Million
0.01% of portfolio
Jpmorgan Chase & CO New York, NY

5.29M
Shares

$436 Million
0.03% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

3.85M
Shares

$317 Million
1.4% of portfolio
Avoro Capital Advisors LLC New York, NY

3.05M
Shares

$252 Million
3.36% of portfolio

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.79B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account